Summary
Shares in the Danish weight-loss drugmaker plummeted after it unveiled plans for more than five 'multi-blockbusters' by 2030 for various ailments.
Ozempic-maker Novo’s shares slide on strategy announcement
Source & full coverage: this summary is aggregated from Free Malaysia Today Business, the original publisher. Read the complete report for full context, data and quotes.
Read the original report at Free Malaysia Today Business →
